日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Early Safety Signal of Sacituzumab Govitecan-Related Toxicity and the UGT1A1*28 Genotype in Metastatic Breast Cancer: A Real-World Preliminary Report

Sacituzumab Govitecan相关毒性及UGT1A1*28基因型在转移性乳腺癌中的早期安全性信号:一项真实世界初步报告

Martínez-Pérez, María; Nieto-Sánchez, María Teresa; Díaz-Villamarín, Xando; Torres-García, Alicia; Fernández-Varón, Emilio; Prados-Carmona, Alvaro; Legerén, Marta; Cabeza-Barrera, José; Blancas, Isabel; Morón, Rocío

Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial

阿特珠单抗联合紫杉醇和贝伐珠单抗一线治疗晚期三阴性乳腺癌:ATRACTIB II期试验

Gion, María; Blancas, Isabel; Cortez-Castedo, Patricia; Cortés-Salgado, Alfonso; Marmé, Frederik; Blanch, Salvador; Morales, Serafín; Díaz, Nieves; Calvo-Plaza, Isabel; Recalde, Sabela; Martínez-Bueno, Alejandro; Ruiz-Borrego, Manuel; Llabrés, Elisenda; Taberner, María Teresa; de Laurentiis, Michelino; García-Vicente, Silvia; Guerrero, José Antonio; Boix, Olga; Rodríguez-Morató, Jose; Sampayo-Cordero, Miguel; Antonarelli, Gabriele; Pérez-García, José Manuel; Cortés, Javier; Llombart-Cussac, Antonio

Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer (PRIMED): an open-label, single-arm, phase 2 trial

预防 HER2 阴性晚期乳腺癌患者接受 sacituzumab govitecan 治疗后出现中性粒细胞减少症和腹泻(PRIMED):一项开放标签、单臂 II 期试验

Pérez-García, José Manuel; Gion, María; Ruiz-Borrego, Manuel; Blancas, Isabel; López-Miranda, Elena; Blanch, Salvador; Recalde, Sabela; Rendo, Cristina Reboredo; González, Xavier; Ancizar, Nerea; Morales, Serafin; Cortez, Patricia; Piwowarska, Zuzanna; Shimizu, Eileen; Guerrero, José Antonio; Sampayo-Cordero, Miguel; Martínez-Bueno, Alejandro; Cortés, Javier; Llombart-Cussac, Antonio

Signature-based repurposed drugs resemble the inhibition of TGFβ-induced NDRG1 as potential therapeutics for triple-negative breast cancer.

基于特征的再利用药物类似于抑制 TGFβ 诱导的 NDRG1,可作为三阴性乳腺癌的潜在疗法

López-Tejada Araceli, Blaya-Cánovas Jose L, Cara Francisca E, Calahorra Jesús, Ramírez-Tortosa César, Blancas Isabel, Delgado-Almenta Violeta, Muñoz-Parra Fabiola, Ávalos-Moreno Marta, Sánchez Ana, González-González Adrián, Marchal Juan A, Griñán-Lisón Carmen, Granados-Principal Sergio

Molecular characterization of pregnancy-associated breast cancer and insights on timing from GEICAM-EMBARCAM study

GEICAM-EMBARCAM 研究揭示了妊娠相关乳腺癌的分子特征及其发病时机。

Peña-Enríquez, Regina; Bermejo, Begoña; Pollán, Marina; Díaz-Chacón, Alejandra; Jerez Gilarranz, Yolanda; Ponce Lorenzo, José J; Fernández Aramburo, Antonio; Cantos Sánchez de Ibargüen, Blanca; Santaballa Bertrán, Ana; Galve-Calvo, Elena; Jiménez-Arranz, Álvaro; Fernández, Yolanda; Pérez, María Eva; De La Cruz, Susana; Anton-Torres, Antonio; Moreno, Fernando; Vidal-Losada, María Jesús; López-Ceballos, María Helena; Blancas, Isabel; Echarri, María José; Rincón, Raúl; Caballero, Rosalía; Guerrero-Zotano, Ángel; Guil-Luna, Silvia; de la Haba-Rodríguez, Juan

Dose-Limiting Toxicities and the Maximum Tolerated Dose of Irinotecan Based on UGT1A1 Genotypes: A Systematic Review

基于UGT1A1基因型的伊立替康剂量限制性毒性和最大耐受剂量:系统评价

Díaz-Villamarín, Xando; Nieto-Sánchez, María Teresa; Martínez-Pérez, María; Novo-González, Paula; Fernández-Varón, Emilio; Torres-García, Alicia; González Astorga, Beatriz; Blancas, Isabel; Cabeza-Barrera, José; Morón, Rocío

Clinical Pharmacogenetics: Results After Implementation of Preemptive Tests in Daily Routine

临床药物遗传学:日常诊疗中实施预防性检测后的结果

Díaz-Villamarín, Xando; Martínez-Pérez, María; Nieto-Sánchez, María Teresa; Fernández-Varón, Emilio; Torres-García, Alicia; Blancas, Isabel; Cabeza-Barrera, José; Morón, Rocío

TUXEDO-4: phase II study of trastuzumab-deruxtecan in HER2-low breast cancer with new or progressing brain metastases

TUXEDO-4:曲妥珠单抗-德鲁替康治疗HER2低表达伴有新发或进展性脑转移的乳腺癌的II期研究

Marhold, Maximilian; Vaz Batista, Marta; Blancas, Isabel; Morales, Cristina; Saura-Manich, Cristina; Saavedra, Cristina; Ruíz-Borrego, Manuel; Cortez, Patricia; Slebe, Felipe; Campolier, Marta; Santos, Juliana Carvalho; Guerrero-Martínez, José Antonio; Jiménez-Cortegana, Carlos; Rottenmanner, Beate; Forstner, Heidrun; Bartsch, Rupert; Preusser, Matthias

Influence of CYP2D6 polymorphisms on tamoxifen side effects in patients with breast cancer

CYP2D6多态性对乳腺癌患者他莫昔芬副作用的影响

Blancas, Isabel; Linares-Rodríguez, Marina; Rodríguez-González, Carlos José; Rodríguez-Serrano, Fernando

Preventing alpelisib-related hyperglycaemia in HR+/HER2-/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial

使用二甲双胍预防HR+/HER2-/PIK3CA突变晚期乳腺癌患者接受alpelisib治疗后发生的高血糖症(METALLICA):一项多中心、开放标签、单臂II期临床试验

Llombart-Cussac, Antonio; Pérez-Garcia, José Manuel; Ruiz Borrego, Manuel; Tolosa, Pablo; Blanch, Salvador; Fernández-Ortega, Adela; Urruticoechea, Ander; Blancas, Isabel; Saura, Cristina; Rojas, Beatriz; Bermejo, Begoña; Ponce Lorenzo, José; Gion, María; Cortez-Castedo, Patricia; Llabres, Elisenda; Galve, Elena; Cueva, Juan Fernando; López, Ana; Alonso-Romero, José Luis; González-Santiago, Santiago; Martínez de Dueñas, Eduardo; Ciruelos, Eva; Martrat, Griselda; Gener, Petra; Alcalá-López, Daniel; Sampayo-Cordero, Miguel; Gómez-Peralta, Fernando; Cortés, Javier